{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:50:37Z","timestamp":1765079437785,"version":"3.37.3"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T00:00:00Z","timestamp":1600473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s10147-020-01783-x","type":"journal-article","created":{"date-parts":[[2020,9,19]],"date-time":"2020-09-19T18:02:37Z","timestamp":1600538557000},"page":"87-94","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3567-0405","authenticated-orcid":false,"given":"Hideki","family":"Endoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiro","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Shiozawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuhiro","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukitoshi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noboru","family":"Oriuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,19]]},"reference":[{"key":"1783_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1056\/NEJMoa0900043","volume":"361","author":"B Fischer","year":"2009","unstructured":"Fischer B, Lassen U, Mortensen J et al (2009) Preoperative staging of lung cancer with combined PET-CT. N Engl J Med 361:32\u201339","journal-title":"N Engl J Med"},{"key":"1783_CR2","unstructured":"National Comprehensive Cancer Network\u00ae. NCCN Clinical Practice Guideline in Oncology (NCCN Guideline\u00ae) Non-small cell lung cancer. https:\/\/www2.tri-kobe.org\/nccn\/guideline\/lung\/english Accessed Jun 10, 2019"},{"key":"1783_CR3","unstructured":"The Japan Lung Cancer Society, Japanese guideline for lung cancer treatment, https:\/\/www.haigan.gr.jp\/guideline\/2018\/1\/1\/180101050100.html. Accessed Jun 10, 2019"},{"key":"1783_CR4","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1097\/JTO.0b013e3181d0a4f5","volume":"5","author":"M Paesmans","year":"2010","unstructured":"Paesmans M, Berghmans T, Dusart M et al (2010) Primary tumor standardized uptake value measured on fluorodeoxyglucose positron emission tomography is of prognostic value for survival in non-small cell lung cancer: update of a systematic review and meta-analysis by the European Lung Cancer Working Party for the International Association for the Study of Lung Cancer Staging Project. J Thorac Oncol 5:612\u2013619","journal-title":"J Thorac Oncol"},{"key":"1783_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.2967\/jnumed.114.147561","volume":"56","author":"SY Park","year":"2015","unstructured":"Park SY, Cho A, Yu WS et al (2015) Prognostic value of total lesion glycolysis by 18F-FDG PET\/CT in surgically resected stage IA non-small cell lung cancer. J Nucl Med 56:45\u201349","journal-title":"J Nucl Med"},{"key":"1783_CR6","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jtcvs.2004.11.007","volume":"130","author":"RJ Cerfolio","year":"2005","unstructured":"Cerfolio RJ, Bryant AS, Ohja B et al (2005) The maximum standardized uptake values on positron emission tomography of a non-small cell lung cancer predict stage, recurrence, and survival. J Thorac Cardiovasc Surg 130:151\u2013159","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1783_CR7","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1097\/JTO.0b013e31822a35c3","volume":"6","author":"H Saji","year":"2011","unstructured":"Saji H, Tsuboi M, Yoshida K et al (2011) Prognostic impact of number of resected and involved lymph nodes at complete resection on survival in non-small cell lung cancer. J Thorac Oncol 6:1865\u20131871","journal-title":"J Thorac Oncol"},{"key":"1783_CR8","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1378\/chest.15-0559","volume":"149","author":"Y Shimada","year":"2016","unstructured":"Shimada Y, Saji H, Kato Y et al (2016) The frequency and prognostic impact of pathological microscopic vascular invasion according to tumor size in non-small cell lung cancer. Chest 149:775\u2013785","journal-title":"Chest"},{"key":"1783_CR9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.lungcan.2012.08.004","volume":"78","author":"Y Kudo","year":"2012","unstructured":"Kudo Y, Saji H, Shimada Y et al (2012) Impact of visceral pleural invasion on the survival of patients with non-small cell lung cancer. Lung Cancer 78:153\u2013160","journal-title":"Lung Cancer"},{"key":"1783_CR10","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1097\/JTO.0b013e31821d4384","volume":"6","author":"YL Lv","year":"2011","unstructured":"Lv YL, Yuan DM, Wang K et al (2011) Diagnostic performance of integrated positron emission tomography\/computed tomography for mediastinal lymph node staging in nonsmall cell lung cancer: a bivariate systematic review and meta-analysis. J Thorac Oncol 6:1350\u20131358","journal-title":"J Thorac Oncol"},{"key":"1783_CR11","doi-asserted-by":"publisher","first-page":"e211S","DOI":"10.1378\/chest.12-2355","volume":"143","author":"GA Silvestri","year":"2013","unstructured":"Silvestri GA, Gonzalez AV, Jantz MA et al (2013) Methods for staging non-small cell lung cancer: diagnosis and management of lung cancer, 3rd ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 143:e211S\u2013e250S","journal-title":"Chest"},{"key":"1783_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF02985610","volume":"18","author":"N Shiraki","year":"2014","unstructured":"Shiraki N, Hara M, Ogino H et al (2014) False-positive and true-negative hilar and mediastinal lymph nodes on FDG-PET \u2013 radiological-pathological correlation. Ann Nucl Med 18:23\u201328","journal-title":"Ann Nucl Med"},{"key":"1783_CR13","doi-asserted-by":"crossref","unstructured":"Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer\u2014major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin 2017; 67: 138\u201355","DOI":"10.3322\/caac.21390"},{"key":"1783_CR14","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.1097\/JTO.0000000000000022","volume":"9","author":"R Nakamura","year":"2014","unstructured":"Nakamura R, Inage Y, Tobita R et al (2014) Epidermal growth factor receptor mutations: effect on volume doubling time of non-small-cell lung cancer patients. J Thorac Oncol 9:1340\u20131344","journal-title":"J Thorac Oncol"},{"key":"1783_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.lungcan.2018.06.030","volume":"123","author":"YJ Suh","year":"2018","unstructured":"Suh YJ, Lee HJ, Kim YJ et al (2018) Computed tomography characteristics of lung adenocarcinomas with epidermal growth factor receptor mutation: a propensity score matching study. Lung Cancer 123:52\u201359","journal-title":"Lung Cancer"},{"key":"1783_CR16","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1634\/theoncologist.2010-0300","volume":"16","author":"RH Mak","year":"2011","unstructured":"Mak RH, Digumarthy SR, Muzikansky A et al (2011) Role of 18F-fluorodeoxyglucose positron emission tomography in predicting epidermal growth factor receptor mutations in non-small cell lung cancer. Oncologist 16:319\u2013326","journal-title":"Oncologist"},{"key":"1783_CR17","doi-asserted-by":"publisher","first-page":"e0175622","DOI":"10.1371\/journal.pone.0175622","volume":"12","author":"K Takamochi","year":"2017","unstructured":"Takamochi K, Mogushi K, Kawaji H et al (2017) Correlation of EGFR or KRAS mutation status with 18F-FDG uptake on PET-CT scan in lung adenocarcinoma. PLoS ONE 12:e0175622","journal-title":"PLoS ONE"},{"key":"1783_CR18","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1002\/cncr.22518","volume":"109","author":"YK Kim","year":"2007","unstructured":"Kim YK, Lee KS, Kim BT et al (2007) Mediastinal nodal staging of non-small cell lung cancer using integrated\u00a018F-FDG PET\/CT in a tuberculosis-endemic country: diagnostic efficacy in 674 patients. Cancer 109:1068\u20131077","journal-title":"Cancer"},{"key":"1783_CR19","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.2967\/jnumed.107.048983","volume":"49","author":"M Karam","year":"2008","unstructured":"Karam M, Roberts-Klein S, Shet N et al (2008) Bilateral hilar foci on 18F-FDG PET scan in patients without lung cancer: variables associated with benign and malignant etiology. J Nucl Med 49:1429\u20131436","journal-title":"J Nucl Med"},{"key":"1783_CR20","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1093\/ejcts\/ezs604","volume":"44","author":"Y Miyasaka","year":"2013","unstructured":"Miyasaka Y, Suzuki K, Takamochi K et al (2013) The maximum standardized uptake value of fluorodeoxyglucose positron emission tomography of the primary tumour is a good predictor of pathological nodal involvement in clinical N0 non-small-cell lung cancer. Eur J Cardiothorac Surg 44:83\u201387","journal-title":"Eur J Cardiothorac Surg"},{"key":"1783_CR21","doi-asserted-by":"publisher","first-page":"305","DOI":"10.2152\/jmi.57.305","volume":"57","author":"H Toba","year":"2010","unstructured":"Toba H, Kondo K, Otsuka H et al (2010) Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose-positron emission tomography and computed tomography in patients with primary lung cancer. J Med Invest 57:305\u2013313","journal-title":"J Med Invest"},{"key":"1783_CR22","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1007\/s00259-013-2400-4","volume":"40","author":"S Moon","year":"2013","unstructured":"Moon S, Cho SH, Park LC et al (2013) Metabolic response evaluated by 18F-FDG PET\/CT as a potential screening tool in identifying a subgroup of patients with advanced non-small cell lung cancer for immediate maintenance therapy after first-line chemotherapy. Eur J Nucl Med Mol Imaging 40:1005\u20131013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1783_CR23","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.2967\/jnumed.112.116921","volume":"54","author":"EA Usmanij","year":"2013","unstructured":"Usmanij EA, de Geus-Oei LF, Troost EG et al (2013) 18F-FDG PET early response evaluation of locally advanced non-small cell lung cancer treated with concomitant chemoradiotherapy. J Nucl Med 54:1528\u20131534","journal-title":"J Nucl Med"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01783-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10147-020-01783-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-020-01783-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,19]],"date-time":"2021-09-19T01:05:42Z","timestamp":1632013542000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10147-020-01783-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,19]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["1783"],"URL":"https:\/\/doi.org\/10.1007\/s10147-020-01783-x","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"type":"print","value":"1341-9625"},{"type":"electronic","value":"1437-7772"}],"subject":[],"published":{"date-parts":[[2020,9,19]]},"assertion":[{"value":"20 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Informed consent was obtained from all individual participants included in the study. The study was approved by the Institutional Review Board (R201604-01).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}]}}